Annual general meeting

EQS-News: freenet generates EBITDA of half a billion euros for the first time and proposes dividend increase

Retrieved on: 
Wednesday, March 13, 2024

Driven by customer growth, Group revenues increased by 2.8% to EUR 2,627.3 million (previous year: EUR 2,556.7 million).

Key Points: 
  • Driven by customer growth, Group revenues increased by 2.8% to EUR 2,627.3 million (previous year: EUR 2,556.7 million).
  • With EBITDA growth of 4.5% to EUR 500.2 million (previous year: EUR 478.7 million), the guidance for the 2023 financial year, which was raised during the year (EUR 495 to 505 million), was met.
  • EBITDA is at the centre of the guidance range and reached the half-billion euro mark for the first time.
  • Against this backdrop, freenet is on track to achieve EBITDA of at least EUR 520 million by the end of the 2025 financial year.

EQS-News: Successful completion of a record year for Redcare Pharmacy: growth 49%, adj. EBITDA margin up 3.7pp to 3%; guidance achieved in all its elements.

Retrieved on: 
Wednesday, March 13, 2024

Successful completion of a record year for Redcare Pharmacy: growth 49%, adj.

Key Points: 
  • Successful completion of a record year for Redcare Pharmacy: growth 49%, adj.
  • EBITDA margin 3% for full year 2023, +3.7pp vs. 2022, with major improvements in both DACH and International segments.
  • Full-year guidance for 2024: continuation of both fast sales growth (30-40%) and solidly positive margins (adj.
  • Following positive margins in all four quarters, (iii) the adjusted EBITDA margin for the full year was 3% (guidance range of 1.5% to 3%).

Nordea completes fourth share buy-back programme

Retrieved on: 
Wednesday, March 13, 2024

Nordea has now completed its fourth share buy-back programme announced in April 2023.

Key Points: 
  • Nordea has now completed its fourth share buy-back programme announced in April 2023.
  • From 28 April 2023 to 21 February 2024, Nordea repurchased 97,406,133 of its own shares (FI4000297767) at an average price per share of EUR 10.26.
  • On 26 April 2023, Nordea announced a share buy-back of up to EUR 1.0bn, based on the authorisation granted to the Board by the 2023 Annual General Meeting.
  • Since the inception of the inaugural buy-back programme in October 2021, Nordea has distributed EUR 5.5bn to its shareholders through repurchasing around 544 million shares at an average price of EUR 10.09 per share.

EQS-News: Klöckner & Co presents solid operating income for 2023 and strengthens focus on attractive business areas and core markets

Retrieved on: 
Wednesday, March 13, 2024

The net result from continuing operations was close to break-even, with a net loss of €0.3 million.

Key Points: 
  • The net result from continuing operations was close to break-even, with a net loss of €0.3 million.
  • Klöckner & Co is therefore set to pay a dividend for the third year in a row.
  • The equity ratio was a very solid 45% at the year end, albeit below the prior-year level (December 31, 2022: 51%).
  • Klöckner & Co is thus focusing on its largest market of North America and its attractive European activities in Germany, Austria and Switzerland.

EQS-News: Biotest achieves EBIT forecast for 2023

Retrieved on: 
Wednesday, March 13, 2024

Dreieich, 29 February 2024: According to preliminary and unaudited figures, EBIT improved significantly in the 2023 financial year to € 143 million after € - 16.6 million in the previous year.

Key Points: 
  • Dreieich, 29 February 2024: According to preliminary and unaudited figures, EBIT improved significantly in the 2023 financial year to € 143 million after € - 16.6 million in the previous year.
  • The EBIT achieved is therefore in the middle of the forecast range of € 130 million and € 170 million.
  • In the 2023 financial year, the Biotest Group achieved sales of € 684 million after € 516.1 million in the previous year.
  • Biotest will publish the final figures for the 2023 financial year and the annual report on 28 March 2024.

Notice of ABB’s Annual General Meeting on March 21, 2024

Retrieved on: 
Wednesday, March 13, 2024

Notice of ABB’s Annual General Meeting on March 21, 2024

Key Points: 
  • Notice of ABB’s Annual General Meeting on March 21, 2024
    ABB today published the invitation to its Annual General Meeting (AGM), which will be held on Thursday, March 21, 2024, at 10:00 a.m.
  • The Annual General Meeting 2024 will be held at Halle 550, Birchstrasse 150, 8050 Zurich, Switzerland, and will also be broadcast at go.abb/agm .
  • Shareholders entered in the share register with the right to vote on March 13, 2024, 3:00 p.m. (CET), are entitled to participate in the Annual General Meeting.
  • If you cannot attend our Annual General Meeting in person, you may be represented by proxy.

EQS-News: Results of the Annual General Meeting 2024 for the financial year 2022/23 of BRAIN Biotech AG

Retrieved on: 
Wednesday, March 13, 2024

Zwingenberg, Germany, 12 March 2024 – At today´s Annual General Meeting of BRAIN Biotech AG (Frankfurt Stock Exchange / BNN / ISIN DE0005203947 / WKN 5203949), the shareholders approved all items on the agenda with a clear majority.

Key Points: 
  • Zwingenberg, Germany, 12 March 2024 – At today´s Annual General Meeting of BRAIN Biotech AG (Frankfurt Stock Exchange / BNN / ISIN DE0005203947 / WKN 5203949), the shareholders approved all items on the agenda with a clear majority.
  • The establishment of silent partnerships between BRAIN Biotech AG and Hessen Kapital I GmbH and MBG H Mittelständische Beteiligungsgesellschaft Hessen mbH - for the financing of innovative research projects at the locations in Hesse - received approval rates of over 99% in each case.
  • 65,99 % of the share capital was represented at the time of the voting.
  • In his speech to shareholders, CEO Adriaan Moelker said: "We now have the architecture, the employees, the technology, the customers and the products to further accelerate our economic success.

Funding Circle Plc: Share Repurchase Programme

Retrieved on: 
Wednesday, March 13, 2024

Funding Circle Holdings plc (“Funding Circle”) announces a discretionary programme to purchase ordinary shares of £0.001 each in its share capital (the “Ordinary Shares”) up to a maximum consideration of £25 million (the “Programme”).

Key Points: 
  • Funding Circle Holdings plc (“Funding Circle”) announces a discretionary programme to purchase ordinary shares of £0.001 each in its share capital (the “Ordinary Shares”) up to a maximum consideration of £25 million (the “Programme”).
  • It is expected that, unless terminated earlier, the Programme will end on the date on which the total GBP purchase price of all Ordinary Shares purchased by Funding Circle pursuant to the Programme is equal to, or as close as possible to, £25 million.
  • The Company has appointed its broker, Numis Securities Limited (“Deutsche Numis”), to manage the share buyback programme to repurchase Ordinary Shares on its behalf.
  • Following the expiry of the 2023 AGM repurchase authority, or to the extent that Funding Circle meets the limit of that authority prior to the 2024 AGM, Funding Circle will seek further repurchase authority at the 2024 AGM or an earlier General Meeting.

EQS-News: SIXT grows by 18% to record revenue in 2023 and achieves second-best result in the company’s history

Retrieved on: 
Wednesday, March 13, 2024

Pullach, 1 March 2024 – SIXT continued its growth trajectory in 2023 and achieved record revenue for the second year in a row.

Key Points: 
  • Pullach, 1 March 2024 – SIXT continued its growth trajectory in 2023 and achieved record revenue for the second year in a row.
  • Alexander Sixt, Co-CEO of Sixt SE: “Thanks to our customers’ trust in us and our employees’ excellent work, we were able to once more achieve a record revenue and have obtained the second-best yearly result in our company’s history.
  • We reached our ambitious goals in 2023, both in terms of our business figures and implementation of our strategy.
  • According to SIXT’s estimates, the lower demand compared to combustion engines resulted in a substantial loss of revenue.

EQS-News: GEA sees earnings rise again in fiscal year 2023 and proposes dividend increase

Retrieved on: 
Wednesday, March 13, 2024

Group revenue rose by 8.4 percent organically and by 4.0 percent on a reported basis to EUR 5,373 million.

Key Points: 
  • Group revenue rose by 8.4 percent organically and by 4.0 percent on a reported basis to EUR 5,373 million.
  • “In the face of the numerous challenges in fiscal year 2023, we managed to further improve our key financial figures.
  • EBITDA before restructuring expenses rose by EUR 62 million, or 8.7 percent, to EUR 774.3 million (2022: EUR 712.0 million).
  • Group profit for fiscal year 2023 came to EUR 392.8 million (2022: EUR 401.4 million).